117 related articles for article (PubMed ID: 14579574)
1. Design and synthesis of galectin inhibitors.
Sörme P; Kahl-Knutsson B; Wellmar U; Magnusson BG; Leffler H; Nilsson UJ
Methods Enzymol; 2003; 363():157-69. PubMed ID: 14579574
[No Abstract] [Full Text] [Related]
2. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.
Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H
Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951
[TBL] [Abstract][Full Text] [Related]
3. Thioureido N-acetyllactosamine derivatives as potent galectin-7 and 9N inhibitors.
Salameh BA; Sundin A; Leffler H; Nilsson UJ
Bioorg Med Chem; 2006 Feb; 14(4):1215-20. PubMed ID: 16242339
[TBL] [Abstract][Full Text] [Related]
4. Efficient and expedient two-step pyranose-retaining fluorescein conjugation of complex reducing oligosaccharides: galectin oligosaccharide specificity studies in a fluorescence polarization assay.
Oberg CT; Carlsson S; Fillion E; Leffler H; Nilsson UJ
Bioconjug Chem; 2003; 14(6):1289-97. PubMed ID: 14624646
[TBL] [Abstract][Full Text] [Related]
5. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
6. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R
Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851
[TBL] [Abstract][Full Text] [Related]
7. Lactosamine-Based Derivatives as Tools to Delineate the Biological Functions of Galectins: Application to Skin Tissue Repair.
Dion J; Deshayes F; Storozhylova N; Advedissian T; Lambert A; Viguier M; Tellier C; Dussouy C; Poirier F; Grandjean C
Chembiochem; 2017 Apr; 18(8):782-789. PubMed ID: 28166391
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and detection of galectins.
Pieters RJ
Chembiochem; 2006 May; 7(5):721-8. PubMed ID: 16566049
[TBL] [Abstract][Full Text] [Related]
9. Development of a Sensitive Microarray Platform for the Ranking of Galectin Inhibitors: Identification of a Selective Galectin-3 Inhibitor.
Dion J; Advedissian T; Storozhylova N; Dahbi S; Lambert A; Deshayes F; Viguier M; Tellier C; Poirier F; Téletchéa S; Dussouy C; Tateno H; Hirabayashi J; Grandjean C
Chembiochem; 2017 Dec; 18(24):2428-2440. PubMed ID: 29024281
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, glycosidase activity and X-ray crystallography of 3-amino-sugars.
Maxwell VL; Evinson EL; Emmerson DP; Jenkins PR
Org Biomol Chem; 2006 Jul; 4(14):2724-32. PubMed ID: 16826297
[TBL] [Abstract][Full Text] [Related]
11. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
[TBL] [Abstract][Full Text] [Related]
12. Low micromolar inhibitors of galectin-3 based on 3'-derivatization of N-acetyllactosamine.
Sörme P; Qian Y; Nyholm PG; Leffler H; Nilsson UJ
Chembiochem; 2002 Mar; 3(2-3):183-9. PubMed ID: 11921396
[TBL] [Abstract][Full Text] [Related]
13. Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins.
Cederfur C; Salomonsson E; Nilsson J; Halim A; Oberg CT; Larson G; Nilsson UJ; Leffler H
Glycobiology; 2008 May; 18(5):384-94. PubMed ID: 18263896
[TBL] [Abstract][Full Text] [Related]
14. Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction.
Sörme P; Arnoux P; Kahl-Knutsson B; Leffler H; Rini JM; Nilsson UJ
J Am Chem Soc; 2005 Feb; 127(6):1737-43. PubMed ID: 15701008
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.
Nagae M; Nishi N; Nakamura-Tsuruta S; Hirabayashi J; Wakatsuki S; Kato R
J Mol Biol; 2008 Jan; 375(1):119-35. PubMed ID: 18005988
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.
Cumpstey I; Carlsson S; Leffler H; Nilsson UJ
Org Biomol Chem; 2005 May; 3(10):1922-32. PubMed ID: 15889175
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of a fungal galectin from Agrocybe cylindracea for recognizing sialoconjugate.
Ban M; Yoon HJ; Demirkan E; Utsumi S; Mikami B; Yagi F
J Mol Biol; 2005 Aug; 351(4):695-706. PubMed ID: 16051274
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.
Tejler J; Skogman F; Leffler H; Nilsson UJ
Carbohydr Res; 2007 Sep; 342(12-13):1869-75. PubMed ID: 17407769
[TBL] [Abstract][Full Text] [Related]
20. A bulge binding agent with novel wedge-shape topology for stimulation of DNA triplet repeat strand slippage synthesis.
Liu L; Li H; Yi L; Yang X; Wen X; Xi Z
Bioorg Med Chem Lett; 2008 Dec; 18(23):6184-8. PubMed ID: 18951785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
